Literature DB >> 17016666

Elevated levels of tumour endothelial marker-8 in human breast cancer and its clinical significance.

Gaynor Davies1, Khaled A Rmali, Gareth Watkins, Robert E Mansel, Malcolm D Mason, Wen G Jiang.   

Abstract

Tumour endothelial marker-8 (TEM-8) belongs to a family of endothelial markers that are raised during tumour angiogenesis. We have recently reported aberrant expression of TEMs at the mRNA level in human breast cancer. This study sought to examine the level of TEM-8 expression at the protein and mRNA level in human breast cancer tissue, and in a panel of human breast cancer cell lines. We also wished to determine if TEM-8 can be used as a suitable marker for identifying tumour associated micro-vessels. At the mRNA level more tumours showed positive TEM-8 expression compared to normal background tissue. TEM-8 was detected in a variety of breast cancer cell lines, endothelial cells (HECV) and in a human fibroblast cell line (MRC5) at both the mRNA and protein level. Using immunohistochemistry the distribution of TEM-8 staining was more widespread in invasive breast cancer tissue compared to normal background tissue. Furthermore, the TEM-8 marker was found to be more discriminatory in identifying micro-vessels in tumour endothelium (2.8+/-0.83 vs. normal 1.66+/-0.52; P<0.011), compared to the vWFA marker (1.61+/-0.54 vs. normal 2.71+/-0.76; P<0.009). Raised levels of TEM-8 were associated with shorter survival outcome, but were not correlated to disease-free survival as shown by Kaplan-Meier and Cox regression analysis. We conclude that TEM-8 is a useful marker for identifying tumour associated micro-vessels and that elevated levels are associated with disease progression, which may have some bearing on the prognostic outcome in breast cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17016666

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  17 in total

1.  Imaging tumor endothelial marker 8 using an 18F-labeled peptide.

Authors:  Qimeng Quan; Min Yang; Haokao Gao; Lei Zhu; Xin Lin; Ning Guo; Guixiang Zhang; Henry S Eden; Gang Niu; Xiaoyuan Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-08-04       Impact factor: 9.236

2.  Anti-tumor angiogenesis effect of genetic fusion vaccine encoding murine beta-defensin 2 and tumor endothelial marker-8 in a CT-26 murine colorectal carcinoma model.

Authors:  Ping Liu; Ganfeng Xie; Peiliang Geng; Chenhong Zheng; Jianjun Li; Feng Pan; Zhihua Ruan; Houjie Liang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

3.  TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer.

Authors:  Tiara T Byrd; Kristen Fousek; Antonella Pignata; Christopher Szot; Heba Samaha; Steven Seaman; Lacey Dobrolecki; Vita S Salsman; Htoo Zarni Oo; Kevin Bielamowicz; Daniel Landi; Nino Rainusso; John Hicks; Suzanne Powell; Matthew L Baker; Winfried S Wels; Joachim Koch; Poul H Sorensen; Benjamin Deneen; Matthew J Ellis; Michael T Lewis; Meenakshi Hegde; Bradley S Fletcher; Brad St Croix; Nabil Ahmed
Journal:  Cancer Res       Date:  2017-11-28       Impact factor: 12.701

4.  ANTXR1, a stem cell-enriched functional biomarker, connects collagen signaling to cancer stem-like cells and metastasis in breast cancer.

Authors:  Daohong Chen; Poornima Bhat-Nakshatri; Chirayu Goswami; Sunil Badve; Harikrishna Nakshatri
Journal:  Cancer Res       Date:  2013-07-05       Impact factor: 12.701

5.  Cryo-Electron Microscopy Structure of Seneca Valley Virus Procapsid.

Authors:  Mike Strauss; Nadishka Jayawardena; Eileen Sun; Richard A Easingwood; Laura N Burga; Mihnea Bostina
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

6.  A unique cytogenetic abnormality, t(2;7)(p13.1;p21.3), in a Philadelphia-positive chronic myeloid leukemia.

Authors:  Walid Al-Achkar; Abdulsamad Wafa; Faten Moassass; Thomas Liehr
Journal:  Oncol Lett       Date:  2012-05-17       Impact factor: 2.967

7.  Prognostic value of tumour endothelial markers in patients with endometrial cancer.

Authors:  Nick A Bersinger; Brigitte Schneider; Stephan A Vorburger; Silke Johann; Daniel Candinas; Michael D Mueller
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

8.  Mutations in ANTXR1 cause GAPO syndrome.

Authors:  Viktor Stránecký; Alexander Hoischen; Hana Hartmannová; Maha S Zaki; Amit Chaudhary; Enrique Zudaire; Lenka Nosková; Veronika Barešová; Anna Přistoupilová; Kateřina Hodaňová; Jana Sovová; Helena Hůlková; Lenka Piherová; Jayne Y Hehir-Kwa; Deepthi de Silva; Manouri P Senanayake; Sameh Farrag; Jiří Zeman; Pavel Martásek; Alice Baxová; Hanan H Afifi; Brad St Croix; Han G Brunner; Samia Temtamy; Stanislav Kmoch
Journal:  Am J Hum Genet       Date:  2013-04-18       Impact factor: 11.025

9.  Capillary morphogenesis gene 2 inhibits growth of breast cancer cells and is inversely correlated with the disease progression and prognosis.

Authors:  Lin Ye; Ping-Hui Sun; Muhammad Faraz Arshad Malik; Malcolm D Mason; Wen G Jiang
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-26       Impact factor: 4.553

10.  A FRET-based high throughput screening assay to identify inhibitors of anthrax protective antigen binding to capillary morphogenesis gene 2 protein.

Authors:  Michael S Rogers; Lorna M Cryan; Kaiane A Habeshian; Lauren Bazinet; Thomas P Caldwell; P Christine Ackroyd; Kenneth A Christensen
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.